文献速递间质性肺疾病

食管直径与系统性硬化相关间质性肺病严重度相关但不预示进展

Oesophageal diameter is associated with severity but not progression of systemic sclerosis-associated interstitial lung disease.
PubMed 文献 · Respirology · 2018-04-11

本研究纳入145例系统性硬化相关间质性肺病(SSc-ILD)患者,通过高分辨率CT评估纤维化评分、食管直径和食管裂孔疝。结果显示食管直径每增加1 cm与纤维化评分升高1.8%和FVC降低5.5%相关,食管裂孔疝患者纤维化评分高3.9%,食管直径独立与死亡率相关,但与ILD进展或不对称病变无关。

要点

  • 食管直径每增1 cm与纤维化评分高1.8%、FVC低5.5%相关。
  • 食管裂孔疝患者纤维化评分较无疝者高3.9%。
  • 食管直径独立预测死亡,但不预示ILD进展。

核心结论

  • 食管直径和食管裂孔疝独立与SSc-ILD严重度和死亡率相关,但与ILD进展或不对称病变无关。
  • 食管疾病不太可能是SSc中ILD进展的重要驱动因素。

研究设计与样本

  • 回顾性分析145例SSc-ILD患者的高分辨率CT(HRCT)扫描,评估纤维化评分、食管直径和食管裂孔疝。
  • 采用混合效应模型进行重复测量分析。

主要发现

  • 平均纤维化评分为8.6%,多数患者有轻至中度生理功能损害。
  • 食管直径每增加1 cm,纤维化评分高1.8%,FVC低5.5%(未调整和调整分析P≤0.001)。
  • 食管裂孔疝患者纤维化评分高3.9%,调整分析后差异持续(P=0.001)。
  • 食管直径预测随后一年的纤维化评分恶化(P=0.02),但调整基线纤维化评分后不再显著(P=0.16)。
  • 食管直径独立与死亡率相关(P=0.001),但与不对称病变或大体误吸的影像特征无关。

临床怎么用

  • 在SSc-ILD患者中评估食管直径和食管裂孔疝有助于识别更严重的肺纤维化和更高死亡风险。
  • 食管直径增大不提示ILD会快速进展,临床决策时应综合考虑其他因素。

局限性

  • 原文未明确报告研究设计类型(如回顾性还是前瞻性),仅提及使用HRCT扫描和混合效应模型。
  • 样本量145例,可能存在选择偏倚。
  • 未报告随访时间、具体统计模型细节及混杂因素调整情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: It is unknown whether oesophageal disease is associated with systemic sclerosis-associated interstitial lung disease (SSc-ILD) severity, progression or mortality. METHODS: High-resolution computed tomography (HRCT) scans from 145 SSc-ILD patients were scored for fibrosis score, oesophageal diameter and presence of hiatal hernia. Fibrosis asymmetry was calculated as: (most affected side - least affected side)/(most affected side + least affected side). Mixed effects models were used for repeated measures analyses. RESULTS: Mean fibrosis score was 8.6%, and most patients had mild-to-moderate physiological impairment. Every 1 cm increase in oesophageal diameter was associated with 1.8% higher fibrosis score and 5.5% lower forced vital capacity (FVC; P ≤ 0.001 for unadjusted and adjusted analyses). Patients with hiatal hernia had 3.9% higher fibrosis score, with persistent differences on adjusted analysis (P = 0.001). Oesophageal diameter predicted worsening fibrosis score over the subsequent year (P = 0.02), but not when adjusting for baseline fibrosis score (P = 0.16). Oesophageal diameter was independently associated with mortality (P = 0.001). Oesophageal diameter was not associated with asymmetric disease or radiological features of gross aspiration. CONCLUSION: Oesophageal diameter and hiatal hernia are independently associated with SSc-ILD severity and mortality, but not with ILD progression or asymmetric disease. Oesophageal disease is unlikely to be a significant driver of ILD progression in SSc.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Winstone TA, Hague CJ, Soon J, et al. Oesophageal diameter is associated with severity but not progression of systemic sclerosis-associated interstitial lung disease. Respirology. 2018. PMID: 29641847. doi:10.1111/resp.13309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。